Related Experiment Video
Updated: Jul 31, 2026

Meta-Analysis of the Effectiveness and Safety of Shugan Jieyu Capsules for the Treatment of Insomnia
Published on: February 17, 2023
Perceived benefits in a behavioral-medicine insomnia program: a clinical report
G D Jacobs1, H Benson, R Friedman
1Division of Behavioral Medicine, Deaconess Hospital/Harvard Medical School, Boston, Massachusetts 02215, USA.
Individuals with chronic insomnia experienced significant sleep improvement and reduced medication use after a group behavioral intervention. Gains were maintained at six-month follow-up, indicating lasting benefits.
Area of Science:
- Behavioral Medicine
- Sleep Science
Background:
- Chronic insomnia is a prevalent condition impacting quality of life.
- Spontaneous seeking of treatment suggests patient motivation for improvement.
Purpose of the Study:
- To evaluate the perceived outcomes of individuals with chronic insomnia.
- To assess the effectiveness of a hospital-based behavioral-medicine insomnia program.
Main Methods:
- A group multifactor behavioral intervention was administered to chronic insomnia patients.
- Patient-reported outcomes were collected via questionnaires at posttreatment and 6-month follow-up.
Main Results:
- All patients reported improved sleep posttreatment, with 58% noting significant improvement.
- 91% of sleep medication users reduced or eliminated medication.
- 90% maintained or enhanced sleep improvement at 6-month follow-up.
Conclusions:
- Group multifactor behavioral intervention offers significant benefits for individuals with chronic insomnia.
- The intervention is effective for sleep medication users and those with psychological comorbidity.
- Long-term maintenance of gains suggests specific therapeutic effects rather than nonspecific factors.
More Related Videos
05:34Auricular Acupuncture as a Traditional Chinese Medicine Therapy for Chronic Obstructive Pulmonary Disease Combined with Sleep Disorders
Published on: August 18, 2023
04:59Heat-sensitive Moxibustion as a Traditional Chinese Medicine Therapy for Chronic Obstructive Pulmonary Disease Combined with Insomnia
Published on: May 30, 2025
Related Concept Videos
The Placebo Effect
Blind Procedures
Management of Insomnia
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Insufficient Sleep and Sleep Deprivation
Sleep deprivation is a more severe form of sleep loss...
Insomnia
Multiple factors contribute...